These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15352159)

  • 21. Full body: the importance of the phenotype in evolution.
    Kampis G; Gulyás L
    Artif Life; 2008; 14(3):375-86. PubMed ID: 18489249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multistep skin cancer in mice as a model to study the evolution of cancer cells.
    Kemp CJ
    Semin Cancer Biol; 2005 Dec; 15(6):460-73. PubMed ID: 16039870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-cancer selection as a source of developmental and evolutionary constraints.
    Galis F; Metz JA
    Bioessays; 2003 Nov; 25(11):1035-9. PubMed ID: 14579244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The topology of the possible: formal spaces underlying patterns of evolutionary change.
    Stadler BM; Stadler PF; Wagner GP; Fontana W
    J Theor Biol; 2001 Nov; 213(2):241-74. PubMed ID: 11894994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The population dynamics of cancer: a Darwinian perspective.
    Vineis P; Berwick M
    Int J Epidemiol; 2006 Oct; 35(5):1151-9. PubMed ID: 16987840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Problems in the morphological assessment of the degree of tumor malignancy].
    Kats VA
    Arkh Patol; 1989; 51(12):69-72. PubMed ID: 2629668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-resolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in the MCF10 model.
    Worsham MJ; Pals G; Schouten JP; Miller F; Tiwari N; van Spaendonk R; Wolman SR
    Breast Cancer Res Treat; 2006 Mar; 96(2):177-86. PubMed ID: 16319984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computational analysis of the influence of the microenvironment on carcinogenesis.
    Basanta D; Ribba B; Watkin E; You B; Deutsch A
    Math Biosci; 2011 Jan; 229(1):22-9. PubMed ID: 21044636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An integrative hypothesis about the origin and development of sporadic and familial breast cancer subtypes.
    Melchor L; Benítez J
    Carcinogenesis; 2008 Aug; 29(8):1475-82. PubMed ID: 18596026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A mathematical model of breast cancer development, local treatment and recurrence.
    Enderling H; Chaplain MA; Anderson AR; Vaidya JS
    J Theor Biol; 2007 May; 246(2):245-59. PubMed ID: 17289081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
    Tubiana M
    Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stochastic cancer progression driven by non-clonal chromosome aberrations.
    Heng HH; Stevens JB; Liu G; Bremer SW; Ye KJ; Reddy PV; Wu GS; Wang YA; Tainsky MA; Ye CJ
    J Cell Physiol; 2006 Aug; 208(2):461-72. PubMed ID: 16688757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The long-term evolution of multilocus traits under frequency-dependent disruptive selection.
    van Doorn GS; Dieckmann U
    Evolution; 2006 Nov; 60(11):2226-38. PubMed ID: 17236416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation: an encouraging approach to anticancer therapy.
    Marchal JA; Rodríguez-Serrano F; Campos J; Madeddu R; Boulaiz H; Martínez-Amat A; Carrillo E; Caba O; Prados JC; Vélez C; Melguizo C; Montella A; Aránega A
    Ital J Anat Embryol; 2006; 111(1):45-64. PubMed ID: 16736717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New concepts of molecular biology on gastric carcinogenesis.
    Kountouras J; Zavos C; Chatzopoulos D
    Hepatogastroenterology; 2005; 52(64):1305-12. PubMed ID: 16001683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A stochastic model of cancer initiation including a bystander effect.
    Østby I; Øyehaug L; Steen HB
    J Theor Biol; 2006 Aug; 241(4):751-64. PubMed ID: 16499930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Models of tumor-host interaction as competing populations: implications for tumor biology and treatment.
    Gatenby RA
    J Theor Biol; 1995 Oct; 176(4):447-55. PubMed ID: 8551743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinically significant cancer evolves from transient mutated and/or aneuploid neoplasia by cell fusion to form unstable syncytia that give rise to ecologically viable parasite species.
    Parris GE
    Med Hypotheses; 2005; 65(5):846-50. PubMed ID: 16023792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mutation matrix and the evolution of evolvability.
    Jones AG; Arnold SJ; Bürger R
    Evolution; 2007 Apr; 61(4):727-45. PubMed ID: 17439608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.